Reportstack is one of the largest online libraries of market research publications. We are the fastest growing and most preferred provider of business intelligence in the market today. We partner with the world's top publishers and research houses to bring to you expert analysis, accurate data and market information along with the best customer support and user experience. For more details, please visit www.reportstack.com
Thursday, 18 May 2017
Market Research on Chimeric Antigen Receptor (CAR) T cell Immunotherapy, 2017
Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2017 is a new market research publication announced by Reportstack. This report emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 68 companies, which are active in this field including 29 leading companies with 123 products targeting 44 different antigens and 16 different technologies.
The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis.
Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.
Reports Highlights:• CAR-T cell Therapy Pipeline scenario • Collaborations & partnering deals • Current Prominent Research Areas and Key Players • Pipeline product profiles CAR-T Technologies and Targeted Antigens • Licensing opportunities • Market Drivers and Barriers Scope• Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information • Coverage of global CAR-T cell therapies under development • Competitive landscape of products for key players and related indications • Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation • Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities • Highlights of licensing & collaboration opportunities and funding details • Highlights of latest CAR-T technologies and innovative companies • Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis